image credit: Freepik

Emmecell exits stealth mode as FDA greenlights clinical trials of cornea cell therapy

September 22, 2020

Corneal transplantation can help people who are losing their sight thanks to degenerating corneas, but it’s “probably the most aggressive surgery” that already highly trained corneal specialists do, said Roger Goldberg, M.D., a retinal surgeon. “It’s not a decision they make lightly,” he added.

That’s why Goldberg and his brother, Jeff Goldberg, M.D., a professor and chair of ophthalmology at Stanford University who specializes in glaucoma, started (PDF) Menlo Park, California-based Emmecell, with Jeff as director of the board and Roger as chief financial officer.

Read More on FierceBiotech